Remifentanil Bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .Remifentanil Bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.